AZD-7798

N/A

Report date: 2026/02/20 20:02:00

Base Information

Drug NameAZD-7798
Drug Alias NameAZD-7798
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionC-C chemokine receptor type 9 antagonists
TargetsC-C chemokine receptor type 9
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[30] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcAstrazeneca AbAstraZeneca global R & D (China) Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsCrohn Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A